• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Excessive vulnerability of herpes-infected endothelium to lymphokine-activated lymphocytes: a possible role in lethal viral pneumonitis following bone marrow transplantation.

作者信息

Vercellotti G M, Kotasek D, Jacob H S

机构信息

Department of Medicine, University of Minnesota 55455.

出版信息

Trans Assoc Am Physicians. 1988;101:310-3.

PMID:2855899
Abstract
  1. Lymphokine-activated killer cells are cytotoxic to human umbilical vein endothelial cells in vitro. 2. Cytotoxic efficiency of LAK cells correlates with serine esterase activity. 3. LAK cells generated from bone marrow transplant patients, as compared to normal volunteers, are significantly more cytotoxic for cultured endothelium, which correlates with their elevated serine esterase content and phenotypic NK-cell proportion. 4. Endothelium infected with herpes simplex virus for very brief periods (4 hr) becomes even more vulnerable to LAK cell-mediated injury. 5. Thus, bone marrow transplant patients harbor "primed" lymphocytes, highly liable to become lymphokine-activated killer cells. These cells have an NK phenotype, readily generate cytotoxic serine esterase activity, and manifest a proclivity to damage vascular endothelium--especially virally infected endothelium. We suggest this proclivity may underlie the severe endotheliitis and lethal pulmonary hemorrhage suffered by bone marrow transplant patients infected with herpesviruses.
摘要

相似文献

1
Excessive vulnerability of herpes-infected endothelium to lymphokine-activated lymphocytes: a possible role in lethal viral pneumonitis following bone marrow transplantation.
Trans Assoc Am Physicians. 1988;101:310-3.
2
VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.VLA - 6(CDw49f)是自体或异基因骨髓移植后自然杀伤细胞介导的细胞毒性中的一种重要黏附分子。
Exp Hematol. 1995 Dec;23(14):1530-4.
3
Mechanism of cultured endothelial injury induced by lymphokine-activated killer cells.淋巴因子激活的杀伤细胞诱导培养的内皮细胞损伤的机制。
Cancer Res. 1988 Oct 1;48(19):5528-32.
4
IL2 activated killer cells may contribute to cytomegalovirus induced marrow hypoplasia after bone marrow transplantation.白细胞介素2激活的杀伤细胞可能在骨髓移植后导致巨细胞病毒诱导的骨髓发育不全。
Bone Marrow Transplant. 1991 Feb;7(2):81-7.
5
Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.自然杀伤细胞和淋巴因子激活的杀伤细胞对甲型肝炎病毒感染的成纤维细胞的细胞溶解活性。
J Clin Lab Immunol. 1993;40(2):47-60.
6
Lymphokine activated killer (LAK) cell-mediated endothelial injury: a mechanism for capillary leak syndrome in patients treated with LAK cells and interleukin-2.
Trans Assoc Am Physicians. 1987;100:21-7.
7
Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.小鼠淋巴因子激活的杀伤(LAK)细胞现象分析:效应细胞和祖细胞分化为NK样细胞和T样细胞。
J Immunol. 1987 Jun 1;138(11):3640-5.
8
Isolation and characterization of cytotoxic granules from human lymphokine (interleukin 2) activated killer cells.从人淋巴因子(白细胞介素2)激活的杀伤细胞中分离及鉴定细胞毒性颗粒。
Cancer Res. 1988 Aug 15;48(16):4681-8.
9
Lymphokine-activated killer cells are generated before classical cytotoxic T lymphocytes after bone marrow transplantation in mice.在小鼠骨髓移植后,淋巴因子激活的杀伤细胞比经典细胞毒性T淋巴细胞更早产生。
J Immunol. 1985 Sep;135(3):1702-6.
10
Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.大鼠中的淋巴因子激活的杀伤细胞:组织和品系分布、个体发生及靶标特异性分析
Cancer Res. 1988 Feb 15;48(4):878-83.

引用本文的文献

1
Effects of Hematopoietic Cell Transplantation on the Pulmonary Immune Response to Infection.造血细胞移植对肺部感染免疫反应的影响。
Front Pediatr. 2021 Jan 26;9:634566. doi: 10.3389/fped.2021.634566. eCollection 2021.
2
Recognition of heterogeneous lymphokine-activated killer (LAK) receptors on Kaposi's sarcoma cells, endothelial cells, and monocytes/macrophages: evidence of distinct LAK-cell antigen on Kaposi's sarcoma cells--potential for use of LAK cells for immunotherapy.对卡波西肉瘤细胞、内皮细胞和单核细胞/巨噬细胞上异质性淋巴因子激活的杀伤细胞(LAK)受体的识别:卡波西肉瘤细胞上存在独特LAK细胞抗原的证据——LAK细胞用于免疫治疗的潜力。
J Clin Immunol. 1992 Jul;12(4):281-8. doi: 10.1007/BF00918152.